BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1380037)

  • 1. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP; Bruce AG
    New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
    Tomida M
    Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCL transcription factor and differential regulation of macrophage differentiation by LIF, OSM and IL-6.
    Begley CG
    Stem Cells; 1994; 12 Suppl 1():143-9; discussion 149-51. PubMed ID: 7696958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
    Lu C; Rak JW; Kobayashi H; Kerbel RS
    Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are LIF and related cytokines functionally equivalent?
    Piquet-Pellorce C; Grey L; Mereau A; Heath JK
    Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
    Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and biological activity of murine oncostatin M.
    Hara T; Ichihara M; Yoshimura A; Miyajima A
    Leukemia; 1997 Apr; 11 Suppl 3():449-50. PubMed ID: 9209421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells.
    Hilton DJ; Nicola NA; Metcalf D
    J Cell Physiol; 1991 Feb; 146(2):207-15. PubMed ID: 1900303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pleiotropic actions of leukemia inhibitory factor.
    Gough NM; Williams RL
    Cancer Cells; 1989 Nov; 1(3):77-80. PubMed ID: 2518284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
    Terada S; Suzuki E; Ueda H; Makishima F
    Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient expression of the IL-2 receptor alpha-chain in IL-6-induced myeloid cells is regulated by autocrine production of prostaglandin E2.
    Ruhl S; Begley CG; Bickel M; Pluznik DH
    Exp Hematol; 1992 Jun; 20(5):619-25. PubMed ID: 1587308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.
    Rose TM; Weiford DM; Gunderson NL; Bruce AG
    Cytokine; 1994 Jan; 6(1):48-54. PubMed ID: 8003633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of differentiation of WEHI-3B D+ leukemic cells transfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA.
    Tomida M
    Blood; 1995 Jan; 85(1):217-21. PubMed ID: 7528568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.
    Rose TM; Bruce AG
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8641-5. PubMed ID: 1717982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.
    Keller JR; Gooya JM; Ruscetti FW
    Blood; 1996 Aug; 88(3):863-9. PubMed ID: 8704242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.
    Tanigawa T; Nicola N; McArthur GA; Strasser A; Begley CG
    Blood; 1995 Jan; 85(2):379-90. PubMed ID: 7811994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.